Study Condition(s): Psoriasis, Psoriatic Arthritis

A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

Study Alias: RHBE

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT02349295 {{ currentLocaleObject.registryAnchorText }}

Withdrawn Active, not recruiting

Study Purpose

The main purpose of this study is to evaluate how effective and safe the study drug known as ixekizumab is in participants with active psoriatic arthritis.

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria


Male Female


18+ years

Time Commitment

Your participation could last up to 3 years and include 24 visits (plus additional follow up visits) to the study center
  • Participant must present with an established diagnosis of active psoriatic arthritis (PsA) for at least 6 months. Active PsA is defined as the presence of at least 3 tender joints and at least 3 swollen joints

  • Participant must have active psoriatic skin lesion(s) or a history of plaque psoriasis (Ps)

  • Participant must have been treated with 1 or more conventional disease-modifying antirheumatic drugs (cDMARDs), but must not be currently using more than one cDMARDs

  • Participant must agree to use a reliable method of birth control or remain abstinent during the study. Females must also remain abstinent for at least 12 weeks after stopping treatment

  • Participant must not be currently using any biologic agents for treatment of Ps or PsA

  • Participant must not have a diagnosis of active inflammatory arthritic syndromes or spondyloarthropathies other than PsA

  • Female participant must not be breastfeeding or nursing

Where to Participate

120 locations are currently available of 120 planned
Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}} {{site.getSiteCTALabel() | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.